Michael N Gladstone

Title: Michael N Gladstone: Innovator in Immunotherapy

Introduction

Michael N Gladstone is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of immunotherapy, holding a total of 6 patents. His work focuses on developing innovative treatments for diseases, particularly cancer.

Latest Patents

Among his latest patents is the development of anti-IL-27 antibodies and their uses. This patent relates to anti-IL-27 antibodies and antigen-binding portions thereof. It also includes methods for treating or ameliorating symptoms of diseases, such as cancer, by administering these antibodies. Additionally, it covers methods for detecting IL-27 in subjects or samples. Another notable patent is for PDE5 compositions and methods for immunotherapy. This invention pertains to compositions and methods for the regulated and controlled expression of proteins, as well as methods for inducing anti-cancer immune responses in subjects.

Career Highlights

Michael has worked with several innovative companies, including Obsidian Therapeutics, Inc. and Surface Oncology, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of groundbreaking therapies.

Collaborations

Throughout his career, Michael has collaborated with notable professionals in the field, including Vipin Suri and Brian Dolinski. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Michael N Gladstone is a key figure in the field of immunotherapy, with a focus on developing innovative treatments for cancer. His contributions through patents and collaborations highlight his commitment to advancing medical science.